Skip to content
Screener

Ardelyx ARDX Total costs & expenses

Total costs & expenses at other companies

Amgen logo
AmgenAMGN
$6.54B+0.3%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$3.47B+75.2%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$33.73M-15.5%
XER
Xeris Biopharma Holdings, Inc.XERS
$86.93M+29.6%
AbbVie logo
AbbVieABBV
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$120.9M+23.8%
Gross profit$115.1M+35.0%
Operating income-$12.4M+13.7%
Net income-$16.7M+12.4%
EPS (diluted)-$0.07+12.5%

Balance sheet

See full
Cash & equivalents$97.2M+7.9%
Total debt$256.2M+24.0%
Total equity$149.0M+6.8%
Total assets$575.9M+23.4%

Cash flow

See full
Operating cash flow-$6.4M+74.7%
CapEx$13.0K-98.0%
Free cash flow-$6.4M+75.3%

Valuation

See full
Market cap$996.75M-23.4%
Enterprise value$1.16B-18.5%
P/S2.2×-1.2×

Profitability

See full
Gross margin94.4%+9.6pp
Operating margin-25.4%
Net margin-12.4%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.7×+0.2×
Current ratio3.3×-1.0×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Ardelyx’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437402-26-000044
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Cost of sales5,75912,40310,57024,706
Research and development26,10315,66646,29130,604
Selling, general and administrative101,44083,988203,707167,210
Total costs and operating expenses133,302112,057260,568222,520
Loss from operations(12,425)(14,395)(45,218)(50,744)
Interest expense(4,957)(4,356)(10,556)(8,547)
Non-cash interest expense related to the sale of future royalties(1,267)(2,219)(2,584)(4,290)
Other income, net2,0381,8924,1504,218

Item 1. Financial Statements (Unaudited)

FAQ

What is Ardelyx's total costs & expenses?
Ardelyx (ARDX) reported total costs & expenses of $133.3M in Q2 2026.
How has Ardelyx's total costs & expenses changed year-over-year?
Ardelyx's total costs & expenses increased by 19.0% year-over-year, from $112.06M to $133.3M.
What is the long-term trend for Ardelyx's total costs & expenses?
Over 4 years (2021 to 2025), Ardelyx's total costs & expenses has grown at a 30.4% compound annual growth rate (CAGR), from $163.44M to $473M.
What does total costs & expenses mean?
This metric represents the aggregate of all operating and non-operating costs incurred by the company during a reporting period, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the total resources consumed to support business operations and commercialization efforts. Monitoring this figure is essential for evaluating the company's overall cost structure and operational efficiency relative to revenue generation.

Ask your AI about Ardelyx's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude